United States Nuclear Regulatory Commission - Protecting People and the Environment

Public Meeting Schedule: Meeting Details

[ New Search ]
Meeting info
Purpose
To solicit comments from the public and stakeholders on the NRC's evaluation of the training and experience (T&E) requirements for a physician to become an authorized user for medical uses under Subpart E, “Unsealed Byproduct Material—Written Directive Required,” of Title 10 of the Code of Federal Regulations (10 CFR) Part 35, “Medical Use of Byproduct Material.” Notice soliciting comments was published in the Federal Register on October 29, 2018 (83 FR 54380).
Meeting Feedback
Meeting Dates and Times
11/14/18
1:00PM - 3:00PM

Webinar
Webinar Link:https://attendee.gotowebinar.com/register/3944692972591850755
Webinar Meeting Number:Webinar ID: 219-367-715
Webinar Password:Not applicable.
Contact
Sarah Lopas
301-415-6360

Participation Level
Category 3
NRC Participants
Office of Nuclear Material Safety and Safeguards
External Participants
Docket Numbers - Facility Names
Related Documents
ML18313A077 - 11/14/2018 Public Meeting (WEBINAR) to Accept Comments on the NRC's Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals (83 FR 54380)

ML18302A095 - Federal Register Notice 83 FR 54380 Training and Experience Requirements for Different Categories of Radiopharmaceuticals.

ML18135A277 - SECY-18-0084: Staff Evaluation of Training and Experience Requirements Administering Different Categories of Radiopharmaceuticals in Response to SRM-M170817

ML18312A413 - Slide Presentation for 11/14/2018 Webinar on NRC Staff Evaluation of Training and Experience Requirements for Different Categories of Radiopharmaceuticals.

Teleconference
Bridge Number: 8884525182
Passcode: 3340287
Comments
Federal Register notice (83 FR 54380) can be accessed at https://www.gpo.gov/fdsys/pkg/FR-2018-10-29/pdf/2018-23521.pdf and also under "Related Documents," above. Additional meetings on this topic will be held on December 11, 2018 (in-person meeting at NRC Headquarters and webinar); January 10, 2019 (in-person meeting at NRC Headquarters and webinar); and January 22, 2019 (webinar-only).